Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

CLEARMIND MEDICINE, INC

Filed by RK STRATEGIES, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2025
Income
$10,000.00
Expenses
Not reported
Filing UUID
7de6b89c-ed2c-4198-bc58-0b01f0f8aced
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Psychedelic Legislation H.R.2623, Innovative Therapies Centers of Excellence Act of 2025

Literal federal measure citations: H.R.2623

DEF · Defense

Psychedelic Legislation H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 H.R. 3838, the Streamlining Procurement for Effective Execution and Delivery Act

Literal federal measure citations: H.R.2623, H.R. 3838

ALC · Alcohol and Drug Abuse

H.R. 3838, the Streamlining Procurement for Effective Execution and Delivery (SPEED) Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Issues Related to Psychedelic Medicines

Literal federal measure citations: H.R. 3838, H.R.2623

VET · Veterans

H.R.2623, Innovative Therapies Centers of Excellence Act of 2025

Literal federal measure citations: H.R.2623

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.